Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2011
02/03/2011US20110027816 Biosensor system, sensor chip, and method of measuring analyte concentration in blood sample
02/03/2011US20110027815 Method of detecting isolevuglandin phospholipid adducts
02/03/2011US20110027814 BRCA1 function-based cellular assays
02/03/2011US20110027807 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
02/03/2011US20110027806 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
02/03/2011US20110027801 EphA KINASE CANCER DIAGNOSTIC
02/03/2011US20110027799 Kit and method for determining whether or not unmethylated cytosine conversion treatment is properly carried out and method for analyzing methylated dna using the same
02/03/2011US20110027798 Hybridization Quantitation Method for Modified Micro-RNA and -DNA Based Oligonucleotides
02/03/2011US20110027797 Method for the Diagnosis of Higher- and Lower-Grade Astrocytoma Using Biomarkers and Diagnostic Kit Thereof
02/03/2011US20110027796 Method for detecting lung cancer using lung cancer-specific methylation marker gene
02/03/2011US20110027795 Cell processing and/or enrichment methods
02/03/2011US20110027794 Method for Synthesizing Nucleic Acids, and Application Thereof
02/03/2011US20110027793 Kit for measuring in vivo mutation frequency at an endogenous gene locus
02/03/2011US20110027792 Assay for mycobacterium avium/intracellulare nucleic acid
02/03/2011US20110027791 Method for generating single-stranded dna molecules representative of a dna sample
02/03/2011US20110027790 Methods of equalizing representation levels of nucleic acid targets
02/03/2011US20110027789 Methods for preservation of genomic dna sequence complexity
02/03/2011US20110027788 Reagent and kit for classifying and counting leukocytes, the preparation thereof, and process for classifying and counting leukocytes
02/03/2011US20110027787 Methods and systems for identifying and isolating stem cells and for observing mitochondrial structure and distribution in living cells
02/03/2011US20110027786 Primers for nucleic acid extension or amplification reactions
02/03/2011US20110027785 Method for determining susceptibility of individuals to polyphenols
02/03/2011US20110027784 Novel Primers for Identification of Astrocytoma, Its Grades and Glioblastoma Prognosis
02/03/2011US20110027783 EXO1 Promotor Polymorphism Associated with Exceptional Life Expectancy in Humans
02/03/2011US20110027782 Probes and methods for detection of pathogens and antibiotic resistance
02/03/2011US20110027781 System for Autonomous Monitoring of Bioagents
02/03/2011US20110027780 Amplification methods
02/03/2011US20110027779 Polynucleotide primers
02/03/2011US20110027778 Composition comprising an oligonucleotide mixture for improved detection of human papillomavirus genotypes
02/03/2011US20110027777 Method for performing prognosis for high-risk breast cancer patients using top2a gene aberrations
02/03/2011US20110027776 Kits and methods for assessing antioxidant requirement of a human
02/03/2011US20110027775 Detection of influenza virus
02/03/2011US20110027774 Highly sensitive method for detection of viral hiv dna remaining after antiretroviral therapy of aids patients
02/03/2011US20110027773 Mass spectrometric methods for detecting mutations in a target nucleic acid
02/03/2011US20110027772 Antigen Detection Kit and Method
02/03/2011US20110027771 Methods and compositions for cell stabilization
02/03/2011US20110027397 Methods of treating autism spectrum disorders and compositions for same
02/03/2011US20110027393 Human diabetes susceptibility eefsec gene
02/03/2011US20110027343 Animal Food Having Low Water Activity
02/03/2011US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides
02/03/2011US20110027300 Identification of a novel cysteine-rich cell penetrating peptide
02/03/2011US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods
02/03/2011US20110027297 Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing
02/03/2011US20110027289 Method for treating synovial sarcoma
02/03/2011US20110027285 Methods and agents modulating upa/upar activity
02/03/2011US20110027270 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
02/03/2011US20110027253 Padlock probe amplification methods
02/03/2011US20110027248 Sugar Chain-Related Gene and Use Thereof
02/03/2011US20110027245 Pairing processes for preparing alloreactive cytotoxic T cells
02/03/2011US20110027235 Targeted integration into stem cells
02/03/2011US20110027234 Methods for identification and selection of human embryonic stem cell derived cells
02/03/2011US20110027231 Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence
02/03/2011US20110027189 Biocompatible products for magnetic particle imaging
02/03/2011US20110027187 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
02/03/2011US20110027186 Taz/wwtr1 for diagnosis and treatment of cancer
02/03/2011US20110027184 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c-like compound administration
02/03/2011US20110027182 Substance for obtaining highly effective tumor medications as well as a process
02/03/2011US20110024391 Methods for creating a surface energy gradient
02/03/2011DE102009035502A1 Verfahren und Vorrichtung zur Erfassung der Bewegung und Anlagerung von Zellen und Partikeln an Zell-, Gewebe- und Implantatschichten bei der Simulation von Flussbedingungen Method and apparatus for detecting the movement and deposition of cells and particles in cell, tissue and implant layers in the simulation of flow conditions
02/03/2011CA2769456A1 Methods and compositions for identifying and validating modulators of cell fate
02/03/2011CA2769311A1 Barley and uses thereof
02/03/2011CA2769302A1 A set of oligonucleotide probes as well as methods and uses related thereto
02/03/2011CA2769006A1 Method and apparatus for conducting an assay
02/03/2011CA2768772A1 Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients
02/03/2011CA2768339A1 Processes and methods for diagnosis of alzheimer's disease
02/03/2011CA2767950A1 Improvements relating to sensor devices
02/02/2011EP2280282A1 Methods of detecting Lp-PLA2 activity
02/02/2011EP2280279A1 Method for evaluation of function of phagocyte
02/02/2011EP2280277A1 Biosensor with flow channel
02/02/2011EP2280276A2 Method and apparatus for rapid electrochemical analysis
02/02/2011EP2280268A1 Multi-array, multi-specific electrochemiluminescence testing
02/02/2011EP2280267A2 Device and method for detecting molecular interactions
02/02/2011EP2280086A1 Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection
02/02/2011EP2280085A2 Compositions and methods for diagnosing colon disorders
02/02/2011EP2280084A1 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
02/02/2011EP2280083A1 Nucleid acid ligand diagnostic biochip
02/02/2011EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
02/02/2011EP2280081A1 Method of normalized quantification of RNA
02/02/2011EP2280080A1 Method of normalized quantification of nucleic acids using anchor oligonucleotides and adapter oligonucleotides
02/02/2011EP2280079A1 Ligation-based method of normalized quantification of nucleic acids
02/02/2011EP2280078A1 Marker for determination of breast cancer, test method, and test kit
02/02/2011EP2280077A1 Method for detection of cancer cell induced by hpv, method for determination concerning whether or not tissue is in later stage of severe dysplasia, and primer set and kit for use in the methods
02/02/2011EP2280070A1 Methods and compositions for RNAi mediated inhibition of gene expression in mammals
02/02/2011EP2280067A2 Novel genes encoding novel proteolytic enzymes
02/02/2011EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
02/02/2011EP2279757A2 Compounds for targeting endothelial cells
02/02/2011EP2279416A2 Method for predicting risk of metastasis
02/02/2011EP2279413A2 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
02/02/2011EP2279411A1 Methods for screening for genetic predisposition to type i diabetes
02/02/2011EP2279405A2 Droplet actuator devices, systems, and methods
02/02/2011EP2279403A1 Highly simplified lateral flow-based nucleic acid sample preparation and passive fluid flow control
02/02/2011EP2279271A2 Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof
02/02/2011EP2279270A1 Markers of acute kidney failure
02/02/2011EP2279269A1 Rapid detection of mycobacteria
02/02/2011EP2279268A1 Scanning system and method for imaging and sequencing
02/02/2011EP2279267A1 Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases
02/02/2011EP2279266A1 A method for detecting igf1r/chr 15 circulating tumor cells using fish
02/02/2011EP2279265A1 Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms
02/02/2011EP2279264A1 Method for characterising the biological activity of helminth eggs, in particular trichuris eggs
02/02/2011EP2279263A2 Rnase-h-based assays utilizing modified rna monomers
02/02/2011EP2279262A2 Measurement of protein kinase activity in cerebrospinal fluid for diagnosis of neurological and psychiatric disorders